medigraphic.com
ISSN 1727-897X (Electronic)

2019, Number 6

<< Back Next >>

Medisur 2019; 17 (6)

Implementation and evaluation of a Guide for the pharmacological management of admitted diabetic patients in the Internal Medicine Service

Corona MLA, Rodríguez AL, Vélez PRR, Borroto LS, Hernández AC

Language: Spanish
References: 14
Page: 833-843
PDF size: 293.55 Kb.


ABSTRACT

Foundation: Diabetes mellitus is a frequent cause of hospital admission. The authors have developed a Guide for the pharmacological therapeutic management of diabetics, which proposes a set of actions aimed at organizing medical care for diabetic patients in the Internal Medicine Service.
Objective: to evaluate the process of implementing a Guide for the pharmacological therapeutic management of admitted diabetic patients with poor metabolic control or uncomplicated acute hyperglycemia status.
Methods: a descriptive study, conducted at Dr. Gustavo Aldereguía Lima Hospital, in Cienfuegos, in May 2018. Compliance with the general actions proposed in the Guide was analyzed, as well as the introduction of the programmed subcutaneous insulin scheme; for this, several "process" and "results" indicators were used.
Results: among the negative results indicators, the following were recorded: glycemic registration at the admission order (49%), patients´ stratification (29%), and stratification quality (60%), among others. Some with positive results were at the admission order to the decompensating factor (82%), adherence to the proposed behavior for each group (86%), use of the programmed subcutaneous insulin scheme (71%), consideration of the decompensation factor in therapeutic management (100%), and overall compliance with the scheme. The metabolic control was progressively achieved.
Conclusion: the feasibility of applying programmed subcutaneous insulin therapy scheme proposed in the Guide, and its usefulness for the metabolic control of patients was confirmed.


REFERENCES

  1. Powers AC. Diabetes Mellitus. En: Harrison. Principios de Medicina Interna. 18a. ed. New York: McGrawHill; 2012. p. 2968-3002.

  2. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States [Internet]. Georgia: CDC; 2012 [citado 23/05/2018]. Disponible en: Disponible en: https://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.

  3. Rydén L, Grant PJ, Anker S, Berne Ch, Cosentino F, Danchin N. Guía de práctica clínica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes. Rev Esp Cardiol. 2014;2(67):136.e1-e56.

  4. Ministerio de Salud Pública. Anuario estadístico de salud. 2012 [Internet]. La Habana: MINSAP; 2013 [citado 03/05/2018]. Disponible en: Disponible en: http://files.sld.cu/dne/files/2013/04/anuario_2012.pdf.

  5. Valdés E, Bencosme N. Las complicaciones macrovasculares y su relación con algunas variables clínicas y bioquímicas en diabéticos tipo 2. Rev Cubana Endocrinol [revista en Internet]. 2010 [citado 03/05/2018];3(21):[aprox. 12p]. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532010000300001.

  6. Hernández A, Tirado OM, Rivas MC, Licea M, Maciquez JE. Factores de riesgo en el desarrollo de la retinopatía diabética. Rev Cub Oftalmol [revista en Internet]. 2011 [citado 03/05/2018];1(24):[aprox. 14p]. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21762017000100005.

  7. Kavanagh BP, Mc Conen KC. Causes and effects of stress hyperglycemia. N Engl J Med. 2010;3(36):2540-6.

  8. Corona LA, Rodríguez L, Vélez R, Borroto S, Hernández C. Elaboración de una guía para el manejo farmacológico de diabéticos hospitalizados en el Servicio de Medicina Interna. Medisur [revista en Internet]. 2019 [citado 11/09/2019];17(5):[aprox. 7p]. Disponible en: Disponible en: http://medisur.sld.cu/index.php/medisur/article/view/4178.

  9. Asociación Americana de Diabetes. Cuidado de la diabetes en el hospital: Estándares de atención médica en Diabetes-2018. Diabetes Care. 2018;41 Suppl 1:99-104.

  10. Balkau B, Simón D. Survival in people with type 2 diabetes as a function of HbA1c. The Lancet. 2016;(375):438-40.

  11. Organización Panamericana de la Salud. Estrategia para la prevención y el control de las enfermedades no transmisibles 2012-2025. Washington: OPS; 2014.

  12. Rodbard HW, Jellinger PS, Davidson JA. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2014;6:540-5.

  13. Arbey W, Montalvo CA. Complicaciones crónicas en pacientes con Diabetes Mellitus, en el hospital universitario de Neiva. Revista Facultad de Salud [revista en Internet]. 2012 [citado 08/06/2018];1(4):[aprox. 8p]. Disponible en: Disponible en: http://www.scielo.sld.cu/scielo.php?script=sci_arttext&pid=pdf102.

  14. Osuna M, Rivera MC, Bocanegra CJ, Lancheros A, Tovar H. Caracterización de la diabetes mellitus tipo 2 y el control metabólico en el paciente hospitalizado. Acta Médica Colombiana [revista en Internet]. 2014 [citado 08/06/2018];4(39):[aprox. 12p]. Disponible en: Disponible en: http://www.scielo.sld.cu/scielo.php?script=sci_arttext&pid=S086403002007000200002&lng=es.




2020     |     www.medigraphic.com